Arbutus Biopharma Corp (NASDAQ:ABUS)

3.29
Delayed Data
As of Apr 09
 +0.01 / +0.30%
Today’s Change
1.00
Today|||52-Week Range
9.02
-7.32%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.75. The median estimate represents a +82.37% increase from the last price of 3.29.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$3.3M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.62%
 
 
 
 
 
 
Growthannually 14.00%
 
 
 
 
 
 

Sales

Growthquarterly 38.49%
 
 
 
 
 
 
Growthannually 112.41%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.